Cantor Fitzgerald, L. P. Cabaletta Bio, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $90.6 Billion
- Q2 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 532,500 shares of CABA stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
532,500
Previous 1,484,585
64.13%
Holding current value
$1.92 Million
Previous $2.06 Million
60.79%
% of portfolio
0.0%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
92Shares Held
79.3MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$34.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$31.9 Million0.02% of portfolio
-
Jennison Associates LLC8.5MShares$30.7 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$24.5 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$18.1 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $105M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...